STOCK TITAN

Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Elanco Animal Health (NYSE: ELAN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference scheduled for Tuesday, January 14, 2025. Jeff Simmons, president and CEO, will represent the company and engage with analysts during a Q&A session at 3:00 p.m. PST (6:00 PM EST).

The event will be accessible through a live audio webcast on the 'Events and Presentations' section of Elanco's investor website, with a replay available for approximately 30 days following the presentation.

Elanco Animal Health (NYSE: ELAN) ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan, programmata per martedì 14 gennaio 2025. Jeff Simmons, presidente e CEO, rappresenterà l'azienda e interagirà con gli analisti durante una sessione di domande e risposte alle 15:00 PST (18:00 EST).

L'evento sarà accessibile tramite un webcast audio dal vivo nella sezione 'Eventi e Presentazioni' del sito web per investitori di Elanco, con una registrazione disponibile per circa 30 giorni dopo la presentazione.

Elanco Animal Health (NYSE: ELAN) ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan programada para el martes 14 de enero de 2025. Jeff Simmons, presidente y CEO, representará a la compañía y se involucrará con analistas durante una sesión de preguntas y respuestas a las 3:00 p.m. PST (6:00 p.m. EST).

El evento será accesible a través de un webcast de audio en vivo en la sección 'Eventos y Presentaciones' del sitio web para inversionistas de Elanco, con una repetición disponible durante aproximadamente 30 días después de la presentación.

엘란코 동물 건강 (NYSE: ELAN)은 2025년 1월 14일 화요일에 예정된 제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. Jeff Simmons 사장 겸 CEO가 회사를 대표하고, 오후 3시 PST (동부 표준시 기준 오후 6시) 동안 분석가들과 질의응답 세션을 진행할 예정입니다.

이번 행사에서는 엘란코의 투자자 웹사이트 '이벤트 및 발표' 섹션에서 실시간 오디오 웹캐스트를 통해 접근할 수 있으며, 프레젠테이션 이후 약 30일간 재생할 수 있는 기회가 제공됩니다.

Elanco Animal Health (NYSE: ELAN) a annoncé sa participation à la 43ème Conférence Annuelle de Santé J.P. Morgan prévue pour le mardi 14 janvier 2025. Jeff Simmons, président et CEO, représentera l'entreprise et échangera avec les analystes lors d'une session de questions-réponses à 15h00 PST (18h00 EST).

L'événement sera accessible via un webcast audio en direct dans la section 'Événements et Présentations' du site web des investisseurs d'Elanco, avec un replay disponible pendant environ 30 jours après la présentation.

Elanco Animal Health (NYSE: ELAN) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben, die für Dienstag, den 14. Januar 2025, geplant ist. Jeff Simmons, Präsident und CEO, wird das Unternehmen vertreten und sich in einer Q&A-Session um 15:00 Uhr PST (18:00 Uhr EST) mit Analysten austauschen.

Die Veranstaltung wird über einen Live-Audio-Webcast im Abschnitt 'Veranstaltungen und Präsentationen' der Investorenseite von Elanco zugänglich sein, mit einer Wiederholung, die für etwa 30 Tage nach der Präsentation verfügbar sein wird.

Positive
  • None.
Negative
  • None.

GREENFIELD, Ind., Dec. 19, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 3:00 p.m. PST (6:00 PM EST).

A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

Investor Contact: Katy Grissom (317) 273-9284 kathryn.grissom@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen_parr_dekker@elancoah.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302336349.html

SOURCE Elanco Animal Health

FAQ

When is Elanco (ELAN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Elanco (ELAN) is presenting at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 3:00 p.m. PST (6:00 PM EST).

How can investors access Elanco's (ELAN) J.P. Morgan Healthcare Conference presentation?

Investors can access Elanco's presentation through a live audio webcast available in the 'Events and Presentations' section of Elanco's investor website. A replay will be available for approximately 30 days after the event.

Who will represent Elanco (ELAN) at the 2025 J.P. Morgan Healthcare Conference?

Jeff Simmons, president and CEO of Elanco, will represent the company at the conference and respond to questions from analysts.

How long will the replay of Elanco's (ELAN) J.P. Morgan Conference presentation be available?

The replay of Elanco's presentation will be available for approximately 30 days following the event on the company's investor website.

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Stock Data

5.82B
490.44M
0.71%
98.94%
3.07%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD